谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

PERIO-02: Phase 1b Pressure Enabled Regional Immuno-Oncology Trial of Nelitolimod (SD-101), a Class C TLR9 Agonist, Delivered Via Hepatic Artery Infusion +/- Checkpoint Inhibition in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.

Sunyoung S. Lee,Khaldoun Almhanna,Rahul Sheth,Shubham Pant,Joshua Kuban, Aaron Wilhelm Palmer Maxwell, Brian Justin Witt,Jason LaPorte,Ann-Marie Hulstine,Bryan Cox,Richard D. Carvajal, Ruth Aroon White,Joshua Weintraub,Lindsey Davis, James Hart,Robert D. Knight,Steven C. Katz,Milind M. Javle

Journal of Clinical Oncology（2024）

引用 0|浏览3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要